• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

132335-47-8 (S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate)

1

Identification

S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate
Name S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate
Formula C21H23NO5S
MW 401.48
CAS No. 132335-47-8
EINECS
Smiles CN(C)CC[[email protected]](OC1=C2C=CC=CC2=CC=C1)C3=CC=CS3.O=C(O)C(O)=O
Synonyms S-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)-1-propanamine oxalate; (S)-N,N-Dimethyl-g-(1-naphthalenyloxy)-2-thiophenepropanamine ethanedioate (1:1); (S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine oxalate
InChI InChI=1S/C19H21NOS.C2H2O4/c1-20(2)13-12-18(19-11-6-14-22-19)21-17-10-5-8-15-7-3-4-9-16(15)17;3-1(4)2(5)6/h3-11,14,18H,12-13H2,1-2H3;(H,3,4)(H,5,6)/t18-;/m0./s1
2

Introduction

Background Information

A duloxetine impurity. ......by BOC Sciences
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB000055437

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways
Target
Research Area
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate

8

Spectral Information

9

Suppliers List

10

Related Products

Other Forms of 132335-47-8

Name CAS No Formula MW

Recommended Compounds in

Name CAS No Formula MW

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate

Tags: buy 132335-47-8 IC50 | 132335-47-8 price | 132335-47-8 cost | 132335-47-8 solubility | 132335-47-8 purchase | 132335-47-8 manufacturer | 132335-47-8 research buy | 132335-47-8 order | 132335-47-8 MSDS | 132335-47-8 chemical structure | 132335-47-8 Storage condition | 132335-47-8 molecular weight | 132335-47-8 mw | 132335-47-8 datasheet | 132335-47-8 supplier | 132335-47-8 cell line | 132335-47-8 NMR | 132335-47-8 MS | 132335-47-8 IR | 132335-47-8 solubility | 132335-47-8 Safe information | 132335-47-8 Qc and Spectral Information | 132335-47-8 Clinical Information | 132335-47-8 Clinical Trial | 132335-47-8 Route of Synthesis | 132335-47-8 storage condition | 132335-47-8 diseases and conditions | 132335-47-8 flash point | 132335-47-8 boiling point | 132335-47-8 melting point | 132335-47-8 storage condition | 132335-47-8 brand